JESSICA SLATTERY: Open Payments
NPI 1245518927 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 92 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $865 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $297 |
| ABBVIE INC. | 26 | $284 |
| Novo Nordisk Inc | 9 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $147 |
| Amgen Inc. | 10 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Exact Sciences Corporation | 4 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Abbott Laboratories | 2 | $40 |
Products named: BREZTRI, CAPLYTA, VRAYLAR, QULIPTA, Wegovy, OTEZLA, JARDIANCE, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
